Dexmedetomidine is a potent and highly selective α2-adrenoreceptor agonist currently
utilized for continuous infusion for sedation/analgesia in the intensive care unit (ICU) …

Background Acute postoperative pain is still an issue in patients undergoing abdominal
surgery. Postoperative pain and side effects of analgesic treatment, in particular those of …

Conclusion Intravenous dexmedetomidine, but not midazolam, prolonged spinal
bupivacaine sensory blockade. It also provided sedation and additional analgesia. Résumé …

Background Since the early 1980s, it has become more and more common to carry out
surgical procedures on a day case basis. Many patients are anxious before surgery yet there …

Study objective An uncontrolled adrenergic response during tracheal intubation may lead to
life-threatening complications. Dexmedetomidine binds to α2-receptors and may attenuate …

Objective: A comparative study to evaluate the efficacy of dexmedetomidine as a
hypotensive agent in comparison to esmolol in Functional Endoscopic Sinus Surgery …

BACKGROUND: Preoperative dexmedetomidine administration blunts haemodynamic and
hormonal responses to tracheal intubation and reduces anaesthetic requirements. We …

Background The surgical stress response plays an important role on the pathogenesis of
perioperative cardiac complications. Alpha‐2 adrenergic agonists attenuate this response …

Conclusion: Dexmedetomidine and esmolol provided better hemodynamic stability and
operative field visibility compared to nitroglycerin during FESS. Dexmedetomidine provides …

Background Dexmedetomidine, an alpha-2 agonist, has been used for attenuation of
hemodynamic response to laryngoscopy but not through the nebulized route. We evaluated …